title: The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region.
authors: Laboratoire d'Immunologie et d'immunomonitoring, CIC INSERM 1408, GIMAP EA3064, CHU de Saint-Etienne, Saint-Etienne, France.
authors: M
authors: M
authors: Rinaudo-Gaujous
authors: Service de Gastro-Entérologie-Hépatologie, CHU de Saint-Etienne, Saint-Etienne, France.
authors: X
authors: X
authors: Roblin
authors: INSERM1059/LBTO, Université Jean Monnet, Université de Lyon and Rheumatology department, CHU de Saint-Etienne, Saint-Etienne, France.
authors: H
authors: H
authors: Marotte
authors: Laboratoire d'Immunologie et d'immunomonitoring, CIC INSERM 1408, GIMAP EA3064, CHU de Saint-Etienne, Saint-Etienne, France.
authors: S
authors: S
authors: Paul
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology*; D057134:Antibodies, Neutralizing / Q000276:immunology*; D018501:Antirheumatic Agents / Q000276:immunology*; D001666:Binding Sites, Antibody / Q000276:immunology*; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing; D018501:Antirheumatic Agents
keywords: Anti-TNF; Autoimmunity; TNF-alpha